PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.000
+0.036 (3.71%)
At close: Oct 8, 2025, 4:00 PM EDT
0.9898
-0.0100 (-1.02%)
Pre-market: Oct 9, 2025, 7:11 AM EDT

PDS Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
476115537623048
Upgrade
Market Cap Growth
-60.08%-60.56%-58.92%63.37%383.52%240.40%
Upgrade
Enterprise Value
343612432816115
Upgrade
Last Close Price
1.001.634.9713.208.102.14
Upgrade
PB Ratio
2.923.215.928.553.641.76
Upgrade
P/TBV Ratio
2.953.215.928.553.641.76
Upgrade
Debt / Equity Ratio
1.161.150.910.530.010.02
Upgrade
Quick Ratio
2.762.444.157.5217.378.82
Upgrade
Current Ratio
2.922.644.337.7917.809.28
Upgrade
Return on Equity (ROE)
-156.16%-166.65%-122.46%-76.21%-37.45%-76.48%
Upgrade
Return on Assets (ROA)
-42.42%-43.34%-39.45%-36.12%-27.32%-41.05%
Upgrade
Return on Capital (ROIC)
-47.70%-49.99%-45.81%-39.71%-29.31%-47.23%
Upgrade
Earnings Yield
-77.83%-61.68%-27.77%-10.86%-7.34%-31.17%
Upgrade
FCF Yield
-73.08%-57.50%-21.76%-6.83%-5.42%-27.60%
Upgrade
Buyback Yield / Dilution
-19.89%-17.77%-8.23%-11.73%-52.86%-243.98%
Upgrade
Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q